Inas Elsayed

431 total citations
11 papers, 83 citations indexed

About

Inas Elsayed is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Inas Elsayed has authored 11 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Inas Elsayed's work include Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (3 papers) and CRISPR and Genetic Engineering (2 papers). Inas Elsayed is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (3 papers) and CRISPR and Genetic Engineering (2 papers). Inas Elsayed collaborates with scholars based in Sudan, Ireland and China. Inas Elsayed's co-authors include Xiaosheng Wang, Sara Bandrés‐Ciga, Bruce Moran, Paula Reyes‐Pérez, Pin‐Jui Kung, Abdulrahim A. Alzain, Kieran Sheahan, Mario Cornejo‐Olivas, Alejandro Martínez-Carrasco and Li Lin and has published in prestigious journals such as Scientific Reports, Movement Disorders and International Immunopharmacology.

In The Last Decade

Inas Elsayed

11 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inas Elsayed Sudan 6 35 20 15 13 13 11 83
Carla Mottini Italy 5 77 2.2× 26 1.3× 3 0.2× 10 0.8× 29 2.2× 7 130
Peiqi Xing China 7 73 2.1× 5 0.3× 12 0.8× 8 0.6× 5 0.4× 9 118
Chiara Starvaggi Cucuzza Sweden 5 20 0.6× 17 0.8× 29 1.9× 2 0.2× 4 0.3× 6 94
Melissa Bennion United States 6 52 1.5× 15 0.8× 8 0.5× 4 0.3× 4 0.3× 8 97
David Kotol Sweden 9 111 3.2× 22 1.1× 5 0.3× 7 0.5× 3 0.2× 15 167
Claire Muller Australia 5 33 0.9× 5 0.3× 24 1.6× 5 0.4× 2 0.2× 11 86
Hayley Donnella United States 5 65 1.9× 33 1.6× 5 0.3× 26 2.0× 4 0.3× 6 112
Seth Weir United States 4 91 2.6× 4 0.2× 5 0.3× 8 0.6× 4 0.3× 8 106
Benjamin A. Turner United States 7 167 4.8× 34 1.7× 3 0.2× 10 0.8× 4 0.3× 14 236
Heribert Arnhof Austria 5 46 1.3× 10 0.5× 4 0.3× 2 0.2× 2 0.2× 8 69

Countries citing papers authored by Inas Elsayed

Since Specialization
Citations

This map shows the geographic impact of Inas Elsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inas Elsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inas Elsayed more than expected).

Fields of papers citing papers by Inas Elsayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inas Elsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inas Elsayed. The network helps show where Inas Elsayed may publish in the future.

Co-authorship network of co-authors of Inas Elsayed

This figure shows the co-authorship network connecting the top 25 collaborators of Inas Elsayed. A scholar is included among the top collaborators of Inas Elsayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inas Elsayed. Inas Elsayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Elsayed, Inas, Njideka Okubadejo, Richard Walker, et al.. (2024). Advancing Parkinson's Disease Research in Africa: A Strategic Training Framework of the Global Parkinson's Genetics Program. Movement Disorders. 40(1). 51–56. 1 indexed citations
2.
Elsayed, Inas, Robert Geraghty, Ahmed Abdalla Mohamedani, et al.. (2022). Evaluating utility and feasibility of mismatch repair testing of colorectal cancer patients in a low-middle-income country. Scientific Reports. 12(1). 10998–10998. 1 indexed citations
3.
Kung, Pin‐Jui, Inas Elsayed, Paula Reyes‐Pérez, & Sara Bandrés‐Ciga. (2022). Immunogenetic Determinants of Parkinson’s Disease Etiology. Journal of Parkinson s Disease. 12(s1). S13–S27. 11 indexed citations
4.
Elsayed, Inas, et al.. (2022). Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer.. PubMed. 33(2). 261–271. 5 indexed citations
5.
Elsayed, Inas, et al.. (2022). Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer. Cancer Biomarkers. 33(2). 261–271. 7 indexed citations
7.
Elsayed, Inas, et al.. (2021). Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors. International Immunopharmacology. 100. 108168–108168. 4 indexed citations
8.
Elsayed, Inas, et al.. (2021). Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Informatics in Medicine Unlocked. 26. 100725–100725. 22 indexed citations
9.
Elsayed, Inas, Alejandro Martínez-Carrasco, Mario Cornejo‐Olivas, & Sara Bandrés‐Ciga. (2021). Mapping the Diverse and Inclusive Future of Parkinson’s Disease Genetics and Its Widespread Impact. Genes. 12(11). 1681–1681. 6 indexed citations
10.
Ahmed, Marwa, et al.. (2021). Preparedness and attitude toward personal protective equipment among house officers during COVID-19 pandemic in Egypt. Journal of Public Health. 43(4). 754–762. 3 indexed citations
11.
Elsayed, Inas & Xiaosheng Wang. (2019). PLK1 Inhibition in Cancer Therapy: Potentials and Challenges. Future Medicinal Chemistry. 11(12). 1383–1386. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026